QUALCOMM, Inc. (NASDAQ:QCOM) Shares Sold by Amica Retiree Medical Trust

Amica Retiree Medical Trust cut its stake in shares of QUALCOMM, Inc. (NASDAQ:QCOM) by 19.2% in the 2nd quarter, according to the company in its …

QUALCOMM logoAmica Retiree Medical Trust cut its stake in shares of QUALCOMM, Inc. (NASDAQ:QCOM) by 19.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,182 shares of the wireless technology company’s stock after selling 1,234 shares during the quarter. Amica Retiree Medical Trust’s holdings in QUALCOMM were worth $394,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of QCOM. Weaver Consulting Group acquired a new stake in QUALCOMM in the first quarter valued at $25,000. Farmers National Bank acquired a new stake in QUALCOMM in the first quarter valued at $26,000. Meridian Wealth Management LLC acquired a new stake in QUALCOMM in the first quarter valued at $26,000. Ibex Wealth Advisors acquired a new stake in QUALCOMM in the second quarter valued at $28,000. Finally, Mark Sheptoff Financial Planning LLC acquired a new stake in QUALCOMM in the first quarter valued at $29,000. 79.55% of the stock is owned by hedge funds and other institutional investors.

A number of equities research analysts have commented on QCOM shares. TheStreet raised QUALCOMM from a “c+” rating to a “b-” rating in a report on Thursday, August 1st. Stifel Nicolaus restated a “buy” rating and issued a $100.00 price target (up previously from $96.00) on shares of QUALCOMM in a research report on Thursday, May 2nd. Morgan Stanley set a $89.00 price target on QUALCOMM and gave the company a “buy” rating in a research report on Wednesday, August 21st. JPMorgan Chase & Co. raised their price target on QUALCOMM from $88.00 to $96.00 and gave the company a “positive” rating in a research report on Thursday, May 2nd. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $84.00 price objective on shares of QUALCOMM in a research report on Thursday, May 2nd. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $79.69.

Shares of NASDAQ:QCOM opened at $74.35 on Thursday. The firm has a market cap of $89.38 billion, a price-to-earnings ratio of 23.31, a PEG ratio of 2.03 and a beta of 1.62. QUALCOMM, Inc. has a 12-month low of $49.10 and a 12-month high of $90.34. The company has a current ratio of 1.77, a quick ratio of 1.61 and a debt-to-equity ratio of 2.46. The stock’s 50-day moving average price is $73.68 and its two-hundred day moving average price is $68.65.

QUALCOMM (NASDAQ:QCOM) last released its quarterly earnings data on Wednesday, July 31st. The wireless technology company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.62 by $0.02. The business had revenue of $4.89 billion for the quarter, compared to analyst estimates of $5.12 billion. QUALCOMM had a return on equity of 112.21% and a net margin of 13.41%. The company’s revenue was down 12.7% compared to the same quarter last year. During the same period in the previous year, the company posted $1.01 EPS. As a group, research analysts forecast that QUALCOMM, Inc. will post 2.84 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 26th. Stockholders of record on Thursday, September 12th will be paid a $0.62 dividend. This represents a $2.48 annualized dividend and a dividend yield of 3.34%. The ex-dividend date is Wednesday, September 11th. QUALCOMM’s dividend payout ratio is currently 77.74%.

In other news, SVP Erin L. Polek sold 1,478 shares of QUALCOMM stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $70.36, for a total value of $103,992.08. Following the transaction, the senior vice president now directly owns 1,386 shares of the company’s stock, valued at approximately $97,518.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.11% of the company’s stock.

QUALCOMM Profile

QUALCOMM Incorporated designs, develops, manufactures, and markets digital communication products worldwide. It operates through three segments: Qualcomm CDMA Technologies (QCT); Qualcomm Technology Licensing (QTL); and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on code division multiple access (CDMA), orthogonal frequency division multiple access, and other technologies for use in wireless voice and data communications, networking, application processing, multimedia, and global positioning system products.

See Also: Beige Book

Institutional Ownership by Quarter for QUALCOMM (NASDAQ:QCOM)

Receive News & Ratings for QUALCOMM Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for QUALCOMM and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

CME Group Inc (NASDAQ:CME) Shares Sold by AGF Investments Inc.

AGF Investments Inc. decreased its holdings in shares of CME Group Inc (NASDAQ:CME) by 21.1% in the 2nd quarter, according to the company in its …

CME Group logoAGF Investments Inc. decreased its holdings in shares of CME Group Inc (NASDAQ:CME) by 21.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,500 shares of the financial services provider’s stock after selling 400 shares during the period. AGF Investments Inc.’s holdings in CME Group were worth $291,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently bought and sold shares of the business. Independent Advisor Alliance raised its holdings in CME Group by 5.9% during the first quarter. Independent Advisor Alliance now owns 1,947 shares of the financial services provider’s stock valued at $321,000 after acquiring an additional 108 shares during the period. Fox Run Management L.L.C. purchased a new position in CME Group in the second quarter worth about $571,000. Jackson Hole Capital Partners LLC grew its position in CME Group by 4.1% in the first quarter. Jackson Hole Capital Partners LLC now owns 1,986 shares of the financial services provider’s stock worth $327,000 after acquiring an additional 79 shares in the last quarter. KC Investment Advisors LLC grew its position in CME Group by 9.0% in the first quarter. KC Investment Advisors LLC now owns 2,898 shares of the financial services provider’s stock worth $477,000 after acquiring an additional 240 shares in the last quarter. Finally, United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund grew its position in CME Group by 609.0% in the first quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund now owns 122,785 shares of the financial services provider’s stock worth $20,208,000 after acquiring an additional 105,468 shares in the last quarter. 85.72% of the stock is owned by institutional investors.

Several research analysts recently commented on the company. Deutsche Bank lifted their price target on CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. UBS Group lifted their price target on CME Group from $190.00 to $194.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 3rd. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a research report on Friday, August 9th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating and set a $158.00 price target for the company. in a research report on Monday, May 27th. Finally, Wells Fargo & Co lifted their price target on CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research report on Wednesday, July 3rd. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have issued a buy rating to the stock. CME Group has an average rating of “Hold” and an average target price of $194.00.

Shares of CME opened at $215.76 on Thursday. The company’s fifty day moving average price is $207.88 and its 200-day moving average price is $188.20. The firm has a market capitalization of $75.64 billion, a PE ratio of 31.64, a price-to-earnings-growth ratio of 4.70 and a beta of 0.23. CME Group Inc has a 1-year low of $161.05 and a 1-year high of $217.65. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 1.05.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.75 by $0.01. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The company’s revenue was up 20.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.74 earnings per share. As a group, research analysts anticipate that CME Group Inc will post 6.68 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be given a $0.75 dividend. The ex-dividend date is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.39%. CME Group’s dividend payout ratio (DPR) is currently 43.99%.

In related news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the completion of the transaction, the chief executive officer now owns 79,057 shares in the company, valued at approximately $15,823,258.55. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Kevin Kometer sold 16,140 shares of the company’s stock in a transaction dated Friday, June 7th. The stock was sold at an average price of $201.19, for a total transaction of $3,247,206.60. Following the transaction, the insider now owns 72,122 shares of the company’s stock, valued at approximately $14,510,225.18. The disclosure for this sale can be found here. In the last quarter, insiders sold 76,771 shares of company stock valued at $15,398,375. Insiders own 1.20% of the company’s stock.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: Why is total return important?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Doliver Advisors LP Increases Stock Holdings in CME Group Inc (NASDAQ:CME)

Doliver Advisors LP lifted its stake in CME Group Inc (NASDAQ:CME) by 18.9% in the second quarter, according to its most recent disclosure with the …

CME Group logoDoliver Advisors LP lifted its stake in CME Group Inc (NASDAQ:CME) by 18.9% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,400 shares of the financial services provider’s stock after purchasing an additional 698 shares during the quarter. Doliver Advisors LP’s holdings in CME Group were worth $854,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Ballentine Partners LLC bought a new position in CME Group during the second quarter valued at approximately $313,000. Wetherby Asset Management Inc. raised its position in CME Group by 2.8% during the second quarter. Wetherby Asset Management Inc. now owns 5,287 shares of the financial services provider’s stock valued at $1,026,000 after acquiring an additional 145 shares in the last quarter. Appleton Partners Inc. MA raised its position in CME Group by 1.3% during the second quarter. Appleton Partners Inc. MA now owns 15,289 shares of the financial services provider’s stock valued at $2,968,000 after acquiring an additional 190 shares in the last quarter. Royal Bank of Scotland Group PLC raised its position in CME Group by 1.3% during the second quarter. Royal Bank of Scotland Group PLC now owns 75,702 shares of the financial services provider’s stock valued at $14,695,000 after acquiring an additional 960 shares in the last quarter. Finally, Arizona State Retirement System raised its position in CME Group by 1.1% during the second quarter. Arizona State Retirement System now owns 127,055 shares of the financial services provider’s stock valued at $24,663,000 after acquiring an additional 1,357 shares in the last quarter. 85.72% of the stock is owned by institutional investors and hedge funds.

Several brokerages recently weighed in on CME. Deutsche Bank raised their price objective on shares of CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research report on Friday, August 9th. BidaskClub raised shares of CME Group from a “hold” rating to a “buy” rating in a research report on Friday, August 9th. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective on the stock. in a research report on Monday, May 27th. Wells Fargo & Co lifted their price target on shares of CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a research report on Wednesday, July 3rd. Finally, Barclays lifted their price target on shares of CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a research report on Thursday, May 23rd. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and eight have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $194.00.

In other CME Group news, Director Daniel R. Glickman sold 500 shares of the business’s stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $216.01, for a total transaction of $108,005.00. Following the completion of the sale, the director now directly owns 14,593 shares of the company’s stock, valued at approximately $3,152,233.93. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy S. Bitsberger sold 700 shares of the business’s stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $194.35, for a total value of $136,045.00. Following the sale, the director now directly owns 9,421 shares of the company’s stock, valued at $1,830,971.35. The disclosure for this sale can be found here. Insiders sold 76,771 shares of company stock valued at $15,398,375 over the last ninety days. 1.20% of the stock is currently owned by company insiders.

CME Group stock opened at $215.76 on Thursday. The stock has a 50-day simple moving average of $207.88 and a 200 day simple moving average of $188.20. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. CME Group Inc has a 12-month low of $161.05 and a 12-month high of $217.65. The stock has a market capitalization of $75.64 billion, a price-to-earnings ratio of 31.64, a P/E/G ratio of 4.70 and a beta of 0.23.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.75 by $0.01. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The business had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. During the same period in the previous year, the business posted $1.74 earnings per share. The firm’s revenue for the quarter was up 20.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that CME Group Inc will post 6.68 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.39%. CME Group’s dividend payout ratio is 43.99%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Recommended Story: Purposes and Functions of the Federal Reserve

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

First Merchants Corp Has $390000 Stock Holdings in CME Group Inc (NASDAQ:CME)

First Merchants Corp cut its position in shares of CME Group Inc (NASDAQ:CME) by 8.7% in the second quarter, according to the company in its most …

CME Group logoFirst Merchants Corp cut its position in shares of CME Group Inc (NASDAQ:CME) by 8.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,008 shares of the financial services provider’s stock after selling 192 shares during the period. First Merchants Corp’s holdings in CME Group were worth $390,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Truvestments Capital LLC purchased a new stake in CME Group during the first quarter valued at approximately $32,000. Close Asset Management Ltd purchased a new stake in CME Group during the first quarter valued at approximately $34,000. Westside Investment Management Inc. purchased a new stake in CME Group during the second quarter valued at approximately $38,000. Permanens Capital L.P. purchased a new stake in CME Group during the first quarter valued at approximately $41,000. Finally, Berman Capital Advisors LLC raised its holdings in shares of CME Group by 23.9% in the first quarter. Berman Capital Advisors LLC now owns 342 shares of the financial services provider’s stock worth $56,000 after buying an additional 66 shares during the period. 85.72% of the stock is owned by institutional investors.

In other news, COO Julie Holzrichter sold 4,241 shares of the business’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $192.26, for a total value of $815,374.66. Following the completion of the sale, the chief operating officer now owns 46,113 shares of the company’s stock, valued at approximately $8,865,685.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the completion of the transaction, the chief executive officer now directly owns 79,057 shares of the company’s stock, valued at $15,823,258.55. The disclosure for this sale can be found here. In the last quarter, insiders sold 76,771 shares of company stock worth $15,398,375. 1.20% of the stock is owned by company insiders.

CME has been the topic of several recent analyst reports. UBS Group increased their price target on CME Group from $190.00 to $194.00 and gave the stock a “neutral” rating in a report on Wednesday, July 3rd. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research report on Friday, August 9th. Barclays increased their target price on CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a research report on Thursday, May 23rd. Deutsche Bank increased their target price on CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Finally, Wells Fargo & Co raised their price objective on CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research report on Wednesday, July 3rd. Three equities research analysts have rated the stock with a sell rating, five have given a hold rating and eight have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $194.00.

Shares of CME stock opened at $215.76 on Thursday. CME Group Inc has a 12 month low of $161.05 and a 12 month high of $217.65. The company has a market cap of $75.64 billion, a P/E ratio of 31.64, a PEG ratio of 4.70 and a beta of 0.23. The firm has a fifty day moving average price of $207.88 and a 200 day moving average price of $188.20. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.15.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The firm had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. During the same period in the prior year, the company posted $1.74 earnings per share. The firm’s revenue for the quarter was up 20.1% on a year-over-year basis. On average, equities analysts forecast that CME Group Inc will post 6.68 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.39%. CME Group’s dividend payout ratio (DPR) is presently 43.99%.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: Market Perform

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Doliver Advisors LP Boosts Stake in CME Group Inc (NASDAQ:CME)

Doliver Advisors LP boosted its holdings in shares of CME Group Inc (NASDAQ:CME) by 18.9% during the second quarter, according to its most …

CME Group logoDoliver Advisors LP boosted its holdings in shares of CME Group Inc (NASDAQ:CME) by 18.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,400 shares of the financial services provider’s stock after buying an additional 698 shares during the period. Doliver Advisors LP’s holdings in CME Group were worth $854,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Dimensional Fund Advisors LP raised its position in shares of CME Group by 2.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 906,174 shares of the financial services provider’s stock worth $170,463,000 after acquiring an additional 24,717 shares during the last quarter. Geode Capital Management LLC increased its holdings in CME Group by 12.9% in the fourth quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock worth $885,776,000 after purchasing an additional 537,917 shares in the last quarter. Legacy Advisors LLC bought a new stake in CME Group in the first quarter worth approximately $92,000. Sageworth Trust Co increased its holdings in CME Group by 5,233.3% in the first quarter. Sageworth Trust Co now owns 480 shares of the financial services provider’s stock worth $79,000 after purchasing an additional 471 shares in the last quarter. Finally, Forte Capital LLC ADV increased its holdings in CME Group by 0.6% in the first quarter. Forte Capital LLC ADV now owns 26,041 shares of the financial services provider’s stock worth $4,286,000 after purchasing an additional 156 shares in the last quarter. Hedge funds and other institutional investors own 85.72% of the company’s stock.

Shares of CME Group stock opened at $215.76 on Thursday. The stock has a market capitalization of $75.64 billion, a PE ratio of 31.64, a price-to-earnings-growth ratio of 4.70 and a beta of 0.23. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.05 and a current ratio of 1.05. CME Group Inc has a 52 week low of $161.05 and a 52 week high of $217.65. The stock has a 50 day moving average price of $207.88 and a two-hundred day moving average price of $188.20.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.75 by $0.01. The company had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.27 billion. CME Group had a return on equity of 9.14% and a net margin of 39.36%. CME Group’s quarterly revenue was up 20.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.74 earnings per share. Research analysts forecast that CME Group Inc will post 6.68 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be given a dividend of $0.75 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 annualized dividend and a dividend yield of 1.39%. CME Group’s payout ratio is 43.99%.

In other CME Group news, COO Julie Holzrichter sold 4,241 shares of the business’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $192.26, for a total value of $815,374.66. Following the transaction, the chief operating officer now owns 46,113 shares of the company’s stock, valued at $8,865,685.38. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Daniel R. Glickman sold 500 shares of the business’s stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $216.01, for a total value of $108,005.00. Following the completion of the transaction, the director now directly owns 14,593 shares in the company, valued at approximately $3,152,233.93. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 76,771 shares of company stock worth $15,398,375. 1.20% of the stock is owned by insiders.

A number of equities research analysts have weighed in on the company. UBS Group lifted their target price on CME Group from $190.00 to $194.00 and gave the stock a “neutral” rating in a report on Wednesday, July 3rd. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a report on Friday, August 9th. Wells Fargo & Co lifted their target price on CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a report on Wednesday, July 3rd. ValuEngine raised CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, May 8th. Finally, Zacks Investment Research cut CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective for the company. in a research note on Monday, May 27th. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and eight have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $194.00.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Recommended Story: Debt-To-Equity Ratio

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts